Whitman-Walker Institute, Cancer Support Community And GRAIL, Subsidiary Of Illumina, Collaborate On Research Aimed At Advancing Health Equity In Cancer Screening And Care Through Multi-Cancer Early Detection
Portfolio Pulse from Happy Mohamed
Whitman-Walker Institute, Cancer Support Community, and GRAIL, a subsidiary of Illumina, have announced a research collaboration aimed at advancing health equity in cancer screening and care. The collaboration will evaluate the Galleri multi-cancer early detection (MCED) test in diverse patient populations. The study will assess the feasibility of implementing the Galleri test in a real-world setting, focusing on groups that have been historically underrepresented in clinical research and care.
August 23, 2023 | 1:07 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Illumina's subsidiary, GRAIL, is collaborating with Whitman-Walker Institute and Cancer Support Community on a research project aimed at advancing health equity in cancer screening and care. This could potentially increase the visibility and usage of GRAIL's Galleri MCED test.
The collaboration could potentially increase the visibility and usage of GRAIL's Galleri MCED test, which could have a positive impact on Illumina's revenues and market position in the long run. However, the actual impact will depend on the success of the research and the subsequent implementation of the test in real-world settings.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100